Fluicell Valuation
| FLUI Stock | SEK 0.05 0 2.72% |
Fluicell seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of Fluicell AB from reviewing the firm fundamentals such as Operating Margin of (8.62) %, shares outstanding of 24.49 M, and Shares Owned By Insiders of 11.20 % as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Fluicell's price fluctuation is out of control at this time. Calculation of the real value of Fluicell AB is based on 3 months time horizon. Increasing Fluicell's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Fluicell's intrinsic value may or may not be the same as its current market price of 0.05, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.05 | Real 0.0431 | Hype 0.05 | Naive 0.0474 |
The intrinsic value of Fluicell's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Fluicell's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Fluicell AB helps investors to forecast how Fluicell stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Fluicell more accurately as focusing exclusively on Fluicell's fundamentals will not take into account other important factors: Fluicell Total Value Analysis
Fluicell AB is currently anticipated to have takeover price of 49.13 M with market capitalization of 73.64 M, debt of 0, and cash on hands of 20.69 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Fluicell fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
49.13 M | 73.64 M | 0 | 20.69 M |
Fluicell Investor Information
The book value of the company was currently reported as 0.76. The company recorded a loss per share of 1.68. Fluicell AB had not issued any dividends in recent years. The entity had 143:128 split on the 4th of October 2022. Fluicell AB is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.Fluicell Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Fluicell has an asset utilization ratio of 9.64 percent. This implies that the Company is making kr0.0964 for each dollar of assets. An increasing asset utilization means that Fluicell AB is more efficient with each dollar of assets it utilizes for everyday operations.Fluicell Ownership Allocation
Fluicell holds a total of 24.49 Million outstanding shares. Fluicell AB shows 11.2 percent of its outstanding shares held by insiders and 0.67 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Fluicell Profitability Analysis
The company reported the revenue of 2.6 M. Net Loss for the year was (21.69 M) with profit before overhead, payroll, taxes, and interest of 1.89 M.About Fluicell Valuation
The stock valuation mechanism determines Fluicell's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Fluicell AB based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Fluicell. We calculate exposure to Fluicell's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Fluicell's related companies.Fluicell AB provides single-cell discovery platforms for biomedicine, drug development, and bioprinting applications worldwide. The company was founded in 2012 and is based in Gothenburg, Sweden. Fluicell operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 17 people.
8 Steps to conduct Fluicell's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Fluicell's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Fluicell's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Fluicell's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Fluicell's revenue streams: Identify Fluicell's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Fluicell's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Fluicell's growth potential: Evaluate Fluicell's management, business model, and growth potential.
- Determine Fluicell's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Fluicell's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Fluicell Stock Analysis
When running Fluicell's price analysis, check to measure Fluicell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fluicell is operating at the current time. Most of Fluicell's value examination focuses on studying past and present price action to predict the probability of Fluicell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fluicell's price. Additionally, you may evaluate how the addition of Fluicell to your portfolios can decrease your overall portfolio volatility.